Global Nanoemulsions 麻豆原创 Research Report 2024

Publication ID:

PB502243252

Publication Date:

February 26, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Emulsion is the process of suspension of small globules of one liquid into other such that the fluids are immiscible with each other. Nanoemulsions are the group of dispersed nano-particles of oil in water having extremely minute size of 100-600 nm. The nanoemulsions are prepared using various emulsification techniques such as microfluidization, high-pressure homogenization and sonication (use of ultrasound energy).
There are several advantages of nanoemulsions over the conventional emulsion systems. One of the major advantages is the extreme micro droplet size of nanoemulsions with much high surface area which makes them highly effective in transportation system or delivery systems used majorly in cosmetics. Moreover, nanoparticles do not cause the problems such as flocculation, coalescence or inherent creaming which are generally faced by microemulsions. This makes nanoemulsions ideal for variety of formulations such creams, sprays and foams.

Considering the extreme small size of these particles, the nanoemulsions are increasingly finding application in pharmaceutical industry, cosmetic industry and also in food sector. The pharmaceutical applications of nanoemulsions majorly dominate the nanoemulsions market, followed by the cosmetic usages. Currently, the market for nanoemulsions is dominated by North America and Europe. Asia Pacific is the fastest growing market for nanoemulsions.
The global Nanoemulsions market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In USA, EU, Japan, China, India and Southeast Asia, Nanoemulsions key players include Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, etc.
USA is the largest market, with a share over 35%, followed by Europe, and Japan, both have a share about 40 percent.
In terms of application, the largest application is Pharmaceutical Industrial, with a share over 45%, followed by Cosmetic Industrial, Food Industrial, etc.
This report aims to provide a comprehensive presentation of the global market for Nanoemulsions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanoemulsions.
Report Scope
The Nanoemulsions market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nanoemulsions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanoemulsions companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Allergan plc
AbbVie Inc.
AstraZeneca Inc.
Fresenius Kabi AG
Kaken Pharmaceutical
GlaxoSmithKline
Novartis AG
Sanofi
B. Braun Melsungen
Segment by Type
Steroids
Anesthetics
NSAIDs
Immunosuppressant
Antiretroviral
Antimicrobials
Vasodilators
Others
Segment by Application
Pharmaceutical Industrial
Cosmetic Industrial
Food Industrial
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanoemulsions companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Nanoemulsions 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Steroids
1.2.3 Anesthetics
1.2.4 NSAIDs
1.2.5 Immunosuppressant
1.2.6 Antiretroviral
1.2.7 Antimicrobials
1.2.8 Vasodilators
1.2.9 Others
1.3 麻豆原创 by Application
1.3.1 Global Nanoemulsions 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Industrial
1.3.3 Cosmetic Industrial
1.3.4 Food Industrial
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanoemulsions 麻豆原创 Perspective (2019-2030)
2.2 Nanoemulsions Growth Trends by Region
2.2.1 Global Nanoemulsions 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nanoemulsions Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Nanoemulsions Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Nanoemulsions 麻豆原创 Dynamics
2.3.1 Nanoemulsions Industry Trends
2.3.2 Nanoemulsions 麻豆原创 Drivers
2.3.3 Nanoemulsions 麻豆原创 Challenges
2.3.4 Nanoemulsions 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanoemulsions Players by Revenue
3.1.1 Global Top Nanoemulsions Players by Revenue (2019-2024)
3.1.2 Global Nanoemulsions Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Nanoemulsions 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanoemulsions Revenue
3.4 Global Nanoemulsions 麻豆原创 Concentration Ratio
3.4.1 Global Nanoemulsions 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanoemulsions Revenue in 2023
3.5 Nanoemulsions Key Players Head office and Area Served
3.6 Key Players Nanoemulsions Product Solution and Service
3.7 Date of Enter into Nanoemulsions 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanoemulsions Breakdown Data by Type
4.1 Global Nanoemulsions Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Nanoemulsions Forecasted 麻豆原创 Size by Type (2025-2030)
5 Nanoemulsions Breakdown Data by Application
5.1 Global Nanoemulsions Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Nanoemulsions Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Nanoemulsions 麻豆原创 Size (2019-2030)
6.2 North America Nanoemulsions 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nanoemulsions 麻豆原创 Size by Country (2019-2024)
6.4 North America Nanoemulsions 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanoemulsions 麻豆原创 Size (2019-2030)
7.2 Europe Nanoemulsions 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nanoemulsions 麻豆原创 Size by Country (2019-2024)
7.4 Europe Nanoemulsions 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanoemulsions 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Nanoemulsions 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nanoemulsions 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Nanoemulsions 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanoemulsions 麻豆原创 Size (2019-2030)
9.2 Latin America Nanoemulsions 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nanoemulsions 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Nanoemulsions 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanoemulsions 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Nanoemulsions 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nanoemulsions 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Nanoemulsions 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan plc
11.1.1 Allergan plc Company Detail
11.1.2 Allergan plc Business Overview
11.1.3 Allergan plc Nanoemulsions Introduction
11.1.4 Allergan plc Revenue in Nanoemulsions Business (2019-2024)
11.1.5 Allergan plc Recent Development
11.2 AbbVie Inc.
11.2.1 AbbVie Inc. Company Detail
11.2.2 AbbVie Inc. Business Overview
11.2.3 AbbVie Inc. Nanoemulsions Introduction
11.2.4 AbbVie Inc. Revenue in Nanoemulsions Business (2019-2024)
11.2.5 AbbVie Inc. Recent Development
11.3 AstraZeneca Inc.
11.3.1 AstraZeneca Inc. Company Detail
11.3.2 AstraZeneca Inc. Business Overview
11.3.3 AstraZeneca Inc. Nanoemulsions Introduction
11.3.4 AstraZeneca Inc. Revenue in Nanoemulsions Business (2019-2024)
11.3.5 AstraZeneca Inc. Recent Development
11.4 Fresenius Kabi AG
11.4.1 Fresenius Kabi AG Company Detail
11.4.2 Fresenius Kabi AG Business Overview
11.4.3 Fresenius Kabi AG Nanoemulsions Introduction
11.4.4 Fresenius Kabi AG Revenue in Nanoemulsions Business (2019-2024)
11.4.5 Fresenius Kabi AG Recent Development
11.5 Kaken Pharmaceutical
11.5.1 Kaken Pharmaceutical Company Detail
11.5.2 Kaken Pharmaceutical Business Overview
11.5.3 Kaken Pharmaceutical Nanoemulsions Introduction
11.5.4 Kaken Pharmaceutical Revenue in Nanoemulsions Business (2019-2024)
11.5.5 Kaken Pharmaceutical Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Detail
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Nanoemulsions Introduction
11.6.4 GlaxoSmithKline Revenue in Nanoemulsions Business (2019-2024)
11.6.5 GlaxoSmithKline Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Detail
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Nanoemulsions Introduction
11.7.4 Novartis AG Revenue in Nanoemulsions Business (2019-2024)
11.7.5 Novartis AG Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Nanoemulsions Introduction
11.8.4 Sanofi Revenue in Nanoemulsions Business (2019-2024)
11.8.5 Sanofi Recent Development
11.9 B. Braun Melsungen
11.9.1 B. Braun Melsungen Company Detail
11.9.2 B. Braun Melsungen Business Overview
11.9.3 B. Braun Melsungen Nanoemulsions Introduction
11.9.4 B. Braun Melsungen Revenue in Nanoemulsions Business (2019-2024)
11.9.5 B. Braun Melsungen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Allergan plc
AbbVie Inc.
AstraZeneca Inc.
Fresenius Kabi AG
Kaken Pharmaceutical
GlaxoSmithKline
Novartis AG
Sanofi
B. Braun Melsungen

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.